Even at therapeutic doses, ibogaine may cause potentially life-threatening cardiac arrhythmia. Science is beginning to unravel the pharmacological factors that may underlie ibogaine-induced cardiotoxicity.
New perspectives on whether mystical experiences have a place in psychedelic science.
Although there are distinct differences between our species, the mouse serotonin 2A receptor plays a crucial role in human psychedelic drug research.
Researchers give us some new data on LSD’s chances of causing bad trips, flashbacks, and other adverse effects.
Scientists know there’s more to magic mushrooms than just psilocybin. But as the psychedelic industry begins taking shape, could the mushroom itself be left behind?
Mescaline is the best-known phenethylamine in psychedelic cacti; but what about the other “minor” compounds in those cacti?
Data released by Filament Health shows why it’s important to understand the basic chemical makeup of magic mushrooms.
Some studies reveal that serotonin 2A receptor activation may not be necessary for the potential therapeutic effects of psychedelics.
Reviewing early research (1895-1975) on changes in auditory perception.
The path toward therapeutic psychedelic-based drugs is becoming clearer as scientists understand more about how they are processed in the body.